The impact we are seeing in OA might be real, but we have to define it more clearly. Although no data are conclusive yet, preclinical studies have shown that GLP-1 receptor agonists can inhibit the NF-kB pathway, a key pathway involved in inflammation and cartilage destruction, according to Lane
It is established that gastroparesis is an unfortunate side effect of GLP-1 medications if taken for weight loss (Sodhi et al
Clothing sizes change by 4 to 6 sizes or more
Nevertheless, I maintain vigilant monitoring of the thyroid in patients on these medications, particularly for those using them longer than 612 months
Tier III Third-party lab Tier III Third-party lab External independent HPLC, ICP-MS, and microbiology by accredited lab
CLM and TMA edited the manuscript, and read and approved the final version of the manuscript and agree with the order of presentation of the authors